SCHEMBL6028748

SCHEMBL6028748

COc1ccc(-c2cnc(SCC(=O)NC(Cc3ccc(Cl)c(F)c3)C3CCCNC3)nc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 4/20 0.39
PDPK1 O15530 1/20 0.37
RPS6KB1 P23443 1/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
TP53 P04637 2/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
JAK3 P52333 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6029095 0.94 CHEK1 (0.39) CHEK1PDPK1RPS6KB1GRIN1GRIN2B
SCHEMBL6028207 0.93 CHEK1 (0.39) CHEK1PDPK1RPS6KB1GRIN1GRIN2B
SCHEMBL6028842 0.93 CHEK1 (0.39) CHEK1PDPK1RPS6KB1GRIN1GRIN2B
SCHEMBL6028518 0.91 CHEK1 (0.39) CHEK1POLBMAPTLMNASMN1; SMN2
SCHEMBL6029187 0.91 MAPT (0.38) CHEK1PDPK1RPS6KB1GRIN1GRIN2B
SCHEMBL6028919 0.90 CHEK1 (0.39) CHEK1JAK1JAK3
SCHEMBL7819214 0.89 AKT1 (0.42) GRIN1GRIN2BTP53MAPTALDH1A1
Hydrochloric Acid SCHEMBL7830259 0.88 AKT1 (0.41) GRIN1GRIN2BTP53MAPTALDH1A1
SCHEMBL6029438 0.86 CHEK1 (0.39) CHEK1GRIN1GRIN2BTP53POLB
SCHEMBL6030080 0.85 MCHR1 (0.44) TP53POLBMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984643-B2 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists ROCHE PALO ALTO LLC (US) 2006-01-10 US disclosed